Current Portfolio
MinervaX
MinervaX is a biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus.
Key Facts
- Sector
Life Sciences
- Country
Denmark
- Fund
LSP 7
- Entry
2023
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.